NCT01957176 2022-12-30A Rollover Study to Provide Continued Treatment With EltrombopagNovartisPhase 4 Completed22 enrolled 9 charts
NCT01610180 2018-07-16Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)Fondazione Progetto EmatologiaPhase 2 Completed18 enrolled